Vet drugmaker Chanelle Group putting €70M into Ireland plant

Ireland-based Chanelle Group, a maker of veterinary generic drugs, has big plans for its manufacturing facility in Loughrea County in Galway. It will invest €70 million ($78 million) to double capacity and will add 175 jobs when it is complete, bringing the company's employment to more than 550 in West Ireland. Construction on the 30,000-square-foot expansion is slated to begin in March, the company said in an announcement. Michael Burke, founder and managing director of Chanelle Group, said the company will also be expanding into new markets, including the U.S. and Central and South America. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.